“By dividing and conquering…we’re seeing responses in multiple different subtypes of sarcoma…and moving toward more of an individualized therapy that we try to design for every patient, where we take ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

For years, electric vehicles have been dogged by a simple, unsettling question: will the battery die long before the rest of ...

LifeVantage Corporation (NASDAQ:LFVN) Q2 2026 Earnings Call Transcript February 4, 2026 LifeVantage Corporation misses on ...

Seasonality matters and winter is especially tough on skin. That's why the best winter creams are so important. As Dr. Alexis ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...

Discover the potential of lab-made antibodies in targeting drug-resistant bacteria and fighting hospital-acquired infections.